Global Platinum Based Drugs Market Share
The markets for platinum-based medications are divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. 2018 saw North America dominate the global market due to the region's rising cancer incidence, the growth of platinum-based medications, and recent FDA approvals. The Asia Pacific market is expected to grow at the fastest rate of compound annual growth (CAGR) as a result of increased disease prevalence, rising per capita income, better health care infrastructure, and rising awareness.